Article Details
Retrieved on: 2022-09-08 18:52:35
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Pfizer (PFE) gets Breakthrough Therapy Designation for GBS vaccine candidate, GBS6, based on an interim analysis of a phase II study.
Article found on: www.zacks.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here